Lux-Lung 6: Patient-Reported Outcomes (Pros) From A Randomized Open-Label, Phase Iii Study In First-Line Advanced Nsclc Patients (Pts) Harboring Epidermal Growth Factor Receptor (Egfr) Mutations
JOURNAL OF CLINICAL ONCOLOGY（2013）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要